Print section
Print Rubric:
Cancer drugs are getting better and dearer
Print Headline:
Hard to swallow
Print Fly Title:
The pharma industry
UK Only Article:
standard article
Issue:
The data economy demands a new approach to antitrust
Fly Title:
Hard to swallow
Main image:
20170506_WBD001_0.jpg
THE debate in rich countries about the high price of drugs is a furious and frustrating one. The controversy is already having an impact on spending on drugs, suggest new figures from the QuintilesIMS Institute, a research firm. The rate of growth in spending on prescription medicines in America fell to 4.8% in 2016, less than half the average rate of the previous two years (after adjusting for discounts and rebates). Michael Levesque of Moody’s, a rating agency, reckons that pressure over pricing is contributing to a deceleration in earnings growth at pharma firms. …Original Article
